Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation

Biochemical and Biophysical Research Communications

Volumn 389, Issue 1, 2009, Pages 105-111

  Wang, Baohua ^a   Shravah, Jayant ^a   Luo, Honglin ^a   Raedschelders, Koen ^a   Chen, David D Y ^a   Ansley, David M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Akt; Apoptosis; Bcl 2; H9c2 cells; Oxidative stress; Propofol

Indexed keywords

HYDROGEN PEROXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROPOFOL; PROTEIN BCL 2; PROTEIN KINASE B; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EMBRYO; ENZYME ACTIVATION; HEART CELL CULTURE; HEART MUSCLE CELL; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANESTHETICS, INTRAVENOUS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CYTOPROTECTION; HYDROGEN PEROXIDE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PHOSPHORYLATION; PROPOFOL; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REPERFUSION INJURY;

RATTUS;

EID: 70349124966     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.097     Document Type: Article

References (26)

1. Kokita N., and Hara A. Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 84 (1996) 117-127
2. Xia Z., Godin D.V., and Ansley D.M. Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. Cardiovasc. Res. 59 (2003) 113-121
3. Xia Z., Godin D.V., Chang T.K., and Ansley D.M. Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. Can. J. Physiol. Pharmacol. 81 (2003) 14-21
4. Ansley D.M., Lee J., Godin D.V., Garnett M.E., and Qayumi A.K. Propofol enhances red cell antioxidant capacity in swine and humans. Can. J. Anaesth. 45 (1998) 233-239
5. Hausenloy D.J., and Yellon D.M. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail. Rev. 12 (2007) 217-234
6. Amaravadi R., and Thompson C.B. The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 115 (2005) 2618-2624
7. Matsui T., and Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J. Mol. Cell Cardiol. 38 (2005) 63-71
8. Luo T., Xia Z., Ansley D.M., Ouyang J., Granville D.J., Li Y., Xia Z.Y., Zhou Q.S., and Liu X.Y. Propofol dose-dependently reduces tumor necrosis factor-alpha-induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth. Analg. 100 (2005) 1653-1659
9. Wang B., Luo T., Chen D., and Ansley D.M. Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth. Analg. 105 (2007) 1027-1033 (table of contents)
10. Scarabelli T., Stephanou A., Rayment N., Pasini E., Comini L., Curello S., Ferrari R., Knight R., and Latchman D. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104 (2001) 253-256
11. Xu J.J., and Wang Y.L. Propofol attenuation of hydrogen peroxide-mediated oxidative stress and apoptosis in cultured cardiomyocytes involves haeme oxygenase-1. Eur. J. Anaesthesiol. 25 (2008) 395-402
12. Pachori A.S., Smith A., McDonald P., Zhang L., Dzau V.J., and Melo L.G. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J. Mol. Cell Cardiol. 43 (2007) 580-592
13. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., and Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 69 (1991) 1476-1486
14. 2-induced apoptosis of H9c2 cardiomyoblasts via activation of extracellular regulated kinases (Erk) 1/2. Am. J. Chin. Med. 34 (2006) 695-706
15. Raedschelders K., Hui Y., Laferlita B., Luo T., Zhang H., Chen D.D., and Ansley D.M. Target-achieved propofol concentration during on-pump cardiac surgery: a pilot dose-finding study. Can. J. Anaesth. (2009)
16. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
17. Corcoran T.B., Engel A., Sakamoto H., O'Shea A., O'Callaghan-Enright S., and Shorten G.D. The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br. J. Anaesth. 97 (2006) 825-831
18. Javadov S.A., Lim K.H., Kerr P.M., Suleiman M.S., Angelini G.D., and Halestrap A.P. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc. Res. 45 (2000) 360-369
19. Tanaka S., Kanaya N., Homma Y., Damron D.S., and Murray P.A. Propofol increases pulmonary artery smooth muscle myofilament calcium sensitivity: role of protein kinase C. Anesthesiology 97 (2002) 1557-1566
20. 2+ sensitivity via a protein kinase C-, nitric oxide synthase-dependent pathway in diabetic cardiomyocytes. Anesthesiology 104 (2006) 978-987
21. Maulik N., Engelman R.M., Rousou J.A., Flack III J.E., Deaton D., and Das D.K. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 100 (1999) II369-II375
22. Negoro S., Oh H., Tone E., Kunisada K., Fujio Y., Walsh K., Kishimoto T., and Yamauchi-Takihara K. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 103 (2001) 555-561
23. Gustin J.A., Korgaonkar C.K., Pincheira R., Li Q., and Donner D.B. Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52. J. Biol. Chem. 281 (2006) 16473-16481
24. Luo J.L., Kamata H., and Karin M. The anti-death machinery in IKK/NF-kappaB signaling. J. Clin. Immunol. 25 (2005) 541-550
25. Lecour S. Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?. J. Mol. Cell Cardiol. 46 (2009) 607-609
26. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., and Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol. Ther. 120 (2008) 172-185